Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine the bioavailability and biologic effect of alendronate on bone
metabolism in patients with cystic fibrosis.
II. Assess the safety and efficacy of this treatment regimen in improving osteoporosis in
this patient population.